1. Cancer Statistics, 2002
2. Technology Appraisal Guidance – No. 45: Guidance on the Use of Pegylated Liposomal Doxorubicin Hydrochloride (PLDH) for the Treatment of Advanced Ovarian Cancer. National Institute for Clinical Excellence, LondonUK 2002; 1–20, www.nice.org.uk (accessed July 2003).
3. Technology Appraisal Guidance – No. 55: Guidance on the Use of Paclitaxel in the Treatment of Ovarian Cancer. National Institute for Clinical Excellence, LondonUK 2003; 1–19, www.nice.org.uk (accessed July 2003)